L-Cystine PharmaGrade, meets EP specifications, manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture

L-Cystine

L-Cystine PharmaGrade, meets EP specifications, manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture
Synonyms:
(R,R)-3,3′-Dithiobis(2-aminopropionicacid), L-Cystine, L-Cystine
Linear Formula:
[-SCH2CH(NH2)CO2H]2
CAS Number:
Molecular Weight:
240.30
EC Number:

Product Comparison Guide

Use the product attributes below to configure the comparison table. (Select up to 3 total.)

Select Attribute
Select Attribute
Select Attribute
Sort By: Default
Product Number
Product Description
Pricing
L-Cystine, ≥98% (TLC), crystalline
L-Cystine, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-101.0%
L-Cystine, ≥99.7% (TLC)
L-Cystine, PharmaGrade, Ajinomoto, EP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
L-Cystine, Pharmaceutical Secondary Standard; Certified Reference Material
L-Cystine, certified reference material, TraceCERT®
L-Cystine, suitable for biopharmaceutical production FCC
L-Cystine, for biochemistry
L-Cystine, produced by Wacker Chemie AG, Burghausen, Germany, ≥98.5%
L-Cystine, PharmaGrade, meets EP specifications, manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.